InMed Pharmaceuticals INM
NASDAQ INM
$1.36 +0.02 (+1.48%)
As of: Oct 21, 2026 · 3:32 PM EDT

InMed Pharmaceuticals (INM) Total Non-Current Liabilities (2020 - 2021)

Updated

InMed Pharmaceuticals' Total Non-Current Liabilities was $166,549 in fiscal Q3 2021 (quarter ended Mar 31, 2021), down 93.0% from the prior quarter.

Analysis

InMed Pharmaceuticals (INM) Total Non-Current Liabilities (2020 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Linde 231.45 Bn 213.03 Bn 4.43 Bn 36.82 Bn
2 Corning 116.59 Bn 109.15 Bn 1.63 Bn 14.10 Bn
3 Sherwin Williams 82.19 Bn 81.23 Bn 3.34 Bn 20.50 Bn
4 Air Products & Chemicals 67.40 Bn 62.58 Bn 1.04 Bn 19.27 Bn
5 LyondellBasell Industries 40.93 Bn 30.44 Bn 2.04 Bn 22.10 Bn
6 Nutrien 33.12 Bn 29.95 Bn 3.25 Bn 27.37 Bn
7 Qnity Electronics 25.20 Bn 22.33 Bn 666.00 Mn 5.75 Bn
8 Ppg Industries 24.54 Bn 17.20 Bn 1.81 Bn 13.30 Bn
9 Ati 24.54 Bn 22.56 Bn 309.80 Mn 3.41 Bn
10 InMed Pharmaceuticals 5.66 Mn 3.46 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 166,549.00
Dec 31, 2020 2.39 Mn
API Access

InMed Pharmaceuticals Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=INM&period=max&api_key=YOUR_API_KEY